Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.

Journal of neurology·2026
Same author

Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.

Multiple sclerosis and related disorders·2025
Same author

Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Perceptual rivalry in neuroscience, magic and philosophy.

Brain : a journal of neurology·2025
Same author

Twin study identifies early immunological and metabolic dysregulation of CD8<sup>+</sup> T cells in multiple sclerosis.

Science immunology·2024
Same author

Correction: Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.

The Journal of experimental medicine·2022

Related Experiment Video

Updated: Jun 17, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009.

Reinhard Hohlfeld1

  • 1Institute of Clinical Neuroimmunology, Ludwig Maximilians University of Munich, München, Germany. reinhard.hohlfeld@med.uni-muenchen.de

Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 17, 2009
PubMed
Summary
This summary is machine-generated.

This review addresses five key challenges in multiple sclerosis (MS) research and treatment, focusing on ethics, risk-benefit optimization, translational research, neuroprotection, and personalized therapy.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Jun 17, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
08:48

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Clinical Neurology

Background:

  • The article summarizes a lecture from the 25th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in 2009.
  • It identifies five critical challenges in the field of multiple sclerosis (MS).

Discussion:

  • Discusses safeguarding medical ethics in MS research and treatment.
  • Explores optimizing the risk/benefit ratio for MS therapies.
  • Addresses the translational gap between multiple sclerosis and experimental autoimmune encephalitis models.
  • Highlights the importance of promoting neuroprotection and repair mechanisms in MS.
  • Covers the challenge of tailoring MS therapy to individual patient needs.

Key Insights:

  • Identifies five major challenges in multiple sclerosis (MS) research and clinical practice.
  • Emphasizes the need for ethical considerations, risk-benefit analysis, and translational research.
  • Stresses the importance of neuroprotection, repair, and personalized treatment strategies for MS patients.

Outlook:

  • Future research should focus on bridging the gap between animal models and human MS.
  • Continued efforts are needed to develop neuroprotective and regenerative therapies for MS.
  • Personalized medicine approaches will be crucial for optimizing MS treatment outcomes.